Effects of ketorolac and dextran-70 alone and in combination on haemostasis

Acta Anaesthesiologica Scandinavica

Volumn 42, Issue 8, 1998, Pages 982-986

  Power, I ^a   Noble, D W ^b   Winter, A ^c   Greer, I A ^d  

^a UNIVERSITY OF SYDNEY   (Australia)

^b ABERDEEN ROYAL INFIRMARY   (United Kingdom)

^c IPSWICH HOSPITAL   (Australia)

^d GLASGOW ROYAL INFIRMARY   (United Kingdom)

Author keywords

Dextran 70; Nonsteroidal anti inflammatory drugs; Plasminogen activator; Platelet function; Skin bleeding time

Indexed keywords

BLOOD CLOTTING FACTOR 8; DEXTRAN; DEXTRAN 70; KETOROLAC; PLACEBO; THROMBOXANE; TISSUE PLASMINOGEN ACTIVATOR; VON WILLEBRAND FACTOR;

ADULT; ARTICLE; BLEEDING TIME; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; HEMOSTASIS; HUMAN; HUMAN EXPERIMENT; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NORMAL HUMAN; PLASMINOGEN ACTIVATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; THROMBOCYTE FUNCTION;

EID: 0031697720     PISSN: 00015172     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-6576.1998.tb05359.x     Document Type: Article

References (20)

1. Spowart K, Greer, IA, McLaren M, Lloyd J, Bullingham R, Forbes CD. Haemostatic effects of ketorolac with and without concomitant heparin in normal volunteers. Thromb Haemost 1988: 60: 382-386.
2. Cashman J, McAnulty G. Nonsteroidal antiinflammatory drugs in postsurgical pain management: mechanisms of action and rationale for optimal use. Drugs 1995: 49: 51-70.
3. Thromboembolic risk factors consensus group. Risk of and prophylaxis for venous thromboembolism in hospital patients. BMJ 1992: 305: 567-574.
4. Berqvist D. The influence of plasma volume expanders on initial haemostasis in the rabbit mesentery. Acta Anaethesiol Scand 1985: 29: 607-609.
5. Bergqvist D. Dextran. In: Bergqvist D, Comerota, AJ, Nicolaidus AN, Scurr JH, eds. Prevention of venous thromboembolism. London: Med-Orion Publishing Company, 1994: 181-198.
6. Matthiasson SE, Lindblad B, Matzsch, T, Molin J, Qvarfordt P, Bergqvist D. Study of the interaction of dextran and enoxaparin on haemostasis in humans. Thromb Haemost 1994: 72: 722-727.
7. Antiplatelet Trialists' Collaboration. Collaborative overview of randomised trials of antiplatelet therapy - III: Reduction in venous thrombosis and pulmonary embolism by antiplatelet prophylaxis among surgical and medical patients. BMJ 1994: 308: 235-246.
8. Data sheet for macrodex (Kabi Pharmacia). ABPI Data Sheet Compendium 1993-94. London: Datapharm Publications, 1993: 729-731.
9. Bergqvist D. Postoperative thromboembolism. New York: Springer Verlag, 1983.
10. Flordsal PA, Ljungstrom KG. Dextran excretion rate in desmopressin treated volunteers. Thromb Res 1995: 79: 131-134.
11. Ivy AC, Nelson D, Bucher G. The standardisation of certain factors in the cutaneous venostasis bleeding time technique. J Lab Clin Med 1941: 26: 1812-1822.
12. Mielke CH, Kaneshiro MM, Maher IA, Weiner JM, Rapaport SI. The standardised normal Ivy bleeding time and its prolongation by aspirin. Blood 1969: 34: 204-215.
13. Greer IA, Walker JJ, McLaren M, Calder AA, Forbes CD. Inhibition of thromboxane and prostacyclin production in whole blood by adrenoceptor antagonists. Prostagland Leuko Med 1985: 19: 209-217.
14. Kelly RW, Deam S, Cameron MJ, Seamark RF. Measurement by radioimmunoassay of prostaglandins as their methyl oximes. Prostagland Leuko Med 1986: 24: 1-14.
15. 2 as the methyl oxime by radioimmunoassay using a novel iodinated label. Prostagland Leuko Med 1989: 37: 187-191.
16. Laurell CB. Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies. Anal Biochem 1966: 15: 45-52.
17. Breckenridge RT, Ratnoff OD. Studies on the nature of the circulating anticoagulant directed against antihemophilic factor: with notes on an assay for antihemophilic factor. Blood 1962: 20: 137-149.
18. MacGregor IR, MacDonald S, Dawes J, Micklem L, James K. A monoclonal antibody enzyme linked immunosorbent assay (ELISA) directed towards a fibrin binding region of tissue-type plasminogen activator. Fibrinolysis 1987: 1: 247-252.
19. Power I, Noble DW, Douglas E, Spence AA. Comparison of i.m. ketorolac trometamol and morphine sulphate for pain relief after cholecystectomy. Br J Anaesth 1990: 65: 448-455.
20. Weiss HJ, Aledort LN, Kochwa S. The effect of salicylates on the haemostatic properties in man. J Clin Invest 1968: 47: 2169-2180.